SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1375)8/27/1998 3:33:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Next week is the 1 year anniversary of the Bluestone Capital financial banker agreement.

Bruce it is obvious that Bluestone wants a price on the remaining 400,000 warrants at these bankrupt levels that have not been priced before they start to support Cistron's stock price. Give them the price so they start working for us on the stock price instead of against us.



To: Rudy Saucillo who wrote (1375)8/28/1998 4:52:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Rudy,

I will have to give accolades to Bluestone Capital and BOD member Naismith....The PMC deal is fantastic!

I have researched PMC even more and am becoming even more excited in the potential fit for Cistron. The exposure and credibility that this will give us should be more than enough to cover the 800,000 warrants they are receiving for bringing us PMC.

Bluestone having 800,000 warrants at these levels should be interesting.

Steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News